Issues related to renewables fuels and E-15 - no specific legislation.
2025 · 4th Quarter (Oct 1 - Dec 31)
NOVOZYMES NORTH AMERICA, INC.
Filed by NOVOZYMES NORTH AMERICA, INC..
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 20, 2026
- Income
- Not reported
- Expenses
- $150,000.00
- Registrant
- NOVOZYMES NORTH AMERICA, INC.
- Filing UUID
- 5da8a68e-ed52-4b07-b9cd-309850bad721
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Issues related to sustainability - no specific legislation. Issues related to animal feed additives, sustainability, renewable fuels, Generally Recognized as Safe (GRAS) Notification Program, and biological product in agriculture - no specific legislation. Issues related to biotechnology and biological products including H.R.2756/S.1387 - National Biotechnology Initiative Act of 2025. Issues related to dietary supplements - no specific legislation.
Issues pertaining to Supply Chain including movement of containers - no specific legislation. SHIP It Act (not yet introduced) - issues related to tariffs.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.